Skip to main content
. 2022 Jul 11;16:100446. doi: 10.1016/j.abrep.2022.100446

Table 1.

Analysis of variables associated with treatment completion among 335 substance-using adolescents and young adults. Chi-square test comparing treatment completers and non-completers.

Completers, n (%)
Non-completers, n (%)
p value
Cannabis use1 259 (97) 63 (95) 0.42
Amphetamine use 26 (10) 9 (14) 0.36
Ecstasy use 41 (15) 18 (27) 0.02*
Cocaine use 53 (20) 21 (32) 0.04*
Heroin use 6 (2) 2 (3) 0.66
Methadone use 0 (0) 0 (0) 1.00
Buprenorphine use 5 (2) 3 (5) 0.20
LSD use 15 (6) 6 (9) 0.30
GHB use 1 (0) 1 (2) 0.36
Spice use 38 (14) 14 (21) 0.17
Solvents use 3 (1) 0 (0) 1.00
Benzodiazepine use 29 (11) 12 (18) 0.11
Opioids 28 (11) 10 (15) 0.29
Anabolic-androgenic steroid use 1 (0) 0 (0) 1.00
Tramadol use 58 (22) 30 (45) <0.001*
Tobacco use regular 196 (74) 53 (80) 0.31
Female gender 66 (25) 18 (27) 0.68
Age 18 years or above 89 (33) 43 (65) <0.001*
Social services contact ever 120 (45) 28 (44) 0.82
Ever treated in residential treatment 48 (19) 14 (21) 0.63
Ever treated in compulsory care for adolescents 8 (3) 3 (5) 0.54
Any previous contact at the present unit 25 (9) 6 (9) 0.94
Any contact with general psychiatry / child and adolescent psychiatry 71 (27) 11 (17) 0.09
Ever treated for drug problems 35 (13) 14 (21) 0.10
Ever treated for alcohol problems 5 (2) 0 (0) 0.26
Ever depressed 173 (66) 51 (79) <0.05*
Ever anxiety 183 (69) 49 (75) 0.34
Suicidal ideation ever 83 (32) 29 (45) <0.05*
Sentenced for crime 59 (24) 22 (38) 0.02*
History of psychiatric health care 121 (46) 29 (45) 0.88
1

Fisher’s exact test used instead of chi-square test.